Expanded Access to Gallium Maltolate (GaM) | MicrobiomeTrials← Back to trialsNCT06404034
Expanded Access to Gallium Maltolate (GaM)
AVAILABLEEXPANDED_ACCESS
Trial Details
Locations- University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
- Cancer Partners of Nebraska, Lincoln, Nebraska, United States
- Northwell Health, New York, New York, United States
Other microbiome trials you might be interested in
High Grade GliomaDiffuse Intrinsic Pontine GliomaAnaplastic AstrocytomaGlioblastomaGlioblastoma MultiformeDiffuse Midline Glioma, H3 K27M-MutantMetastatic Brain TumorWHO Grade III GliomaWHO Grade IV Glioma
The goal of this study is to perform genetic sequencing on brain tumors from children, adolescents, and young adult pati…
Aurora, United StatesEst. completion Aug 28, 2029
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Relapsed Cancer
Recurrent Tumor
Glioblastoma Multiforme
Recurring Glioblastoma
Brain and Central Nervous System Tumors
Glioma
Glioblastomas
Grade IV Astrocytoma
GBM
Recurrent Glioma (Glioblastoma Multiforme)
High Grade Glioma
Glioma, Malignant
Brain Cancer
Background:
Glioblastoma is a common brain cancer in adults. Treatment includes surgery, radiation, and chemotherapy. B…
Bethesda, United StatesEst. completion Dec 31, 2030
GlioblastomaGliosarcoma
The researchers are doing this study to find out whether the drugs ABBV-637 and ABBV-155 are safe treatments that cause …
Los Angeles, United StatesEst. completion Apr 2028